A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Condition(s):Pulmonary Arterial HypertensionLast Updated:September 7, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:September 7, 2020Terminated
Condition(s):Pulmonary Arterial HypertensionLast Updated:May 24, 2016Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:June 14, 2017Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:September 13, 2021Terminated
Condition(s):Hypertension; Pulmonary Arterial Hypertension; Familial Primary Pulmonary Hypertension; Primary Pulmonary Hypertension; Lung Diseases; Tamoxifen; Estrogen Receptor Antagonist; Hormone Antagonists; EstrogensLast Updated:August 1, 2023Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 15, 2024Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 15, 2024Active, not recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 22, 2023Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 28, 2024Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.